Literature DB >> 4560341

Transfer of aminonucleoside nephrosis by renal transplantation.

J R Hoyer, J Ratte, A H Potter, A F Michael.   

Abstract

The pathogenesis of aminonucleoside of puromycin (PA) nephrotic syndrome in rats was studied using renal transplantation to separate systemic from renal factors. The nephrotic syndrome was transferred by transplantation of kidneys from rats with established proteinuria. Bilaterally nephrectomized normal rats receiving kidneys removed as early as 15 min after intravenous PA injection (100 mg/kg) of donors also developed proteinuria (602+/-125 mg/24 hr) and a nephrotic syndrome after the usual induction period of 4-7 days observed in this disease. Arterial perfusion of isolated kidneys with PA (50 mg/kg) followed by perfusion with isotonic saline 3 min later and then transplantation to normal bilaterally nephrectomized rats led to a nephrotic syndrome. Urine protein excretion was 494+/-42 mg on the 7th day after transplantation. In contrast, urine protein excretion after transplantation of normal kidneys to normal bilaterally nephrectomized rats was 40+/-20 mg on the 7th day. Exposure of a normal kidney to a nephrotic host environment by transplantation of a normal kidney to a unilaterally nephrectomized PA-injected rat did not transfer the disease to the normal kidney. After removal of the nephrotic kidney 11-13 days after transplantation, proteinuria of the donor kidney was normal (21+/-13 mg on day 15). These studies indicate that pathogenesis of aminonucleoside nephrosis involves programming of the kidney directly by PA within minutes after exposure although increased urinary protein excretion does not occur until several days later.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4560341      PMCID: PMC332980          DOI: 10.1172/JCI107099

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS. IV. IMMUNOGLOBULINS AND ANTIBODY FORMATION.

Authors:  B G ARNASON; E H RELYVELD
Journal:  Int Arch Allergy Appl Immunol       Date:  1964

2.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Rat glomerular glycoprotein composition and metabolism in aminonucleoside nephrosis.

Authors:  E B Blau; A F Michael
Journal:  Proc Soc Exp Biol Med       Date:  1972-10

4.  Inhibition of aminonucleoside nephrosis in rats. IV. Prevention by N6-methyladenosine.

Authors:  R F Derr; D K Loechler; C S Alexander; H T Nagasawa
Journal:  J Lab Clin Med       Date:  1968-09

5.  Glomerular polyanion. Alteration in aminonucleoside nephrosis.

Authors:  A F Michael; E Blau; R L Vernier
Journal:  Lab Invest       Date:  1970-12       Impact factor: 5.662

6.  Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors:  A F Michael; K N Drummond; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

7.  Micropuncture studies of proximal tubule albumin concentrations in normal and nephrotic rats.

Authors:  D E Oken; W Flamenbaum
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

8.  An ultrastructural study of glomerular permeability in aminonucleoside nephrosis using catalase as a tracer protein.

Authors:  M A Venkatachalam; R S Cotran; M J Karnovsky
Journal:  J Exp Med       Date:  1970-12-01       Impact factor: 14.307

9.  Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats.

Authors:  M G FARQUHAR; G E PALADE
Journal:  J Exp Med       Date:  1961-11-01       Impact factor: 14.307

10.  Aminonucleoside nephrosis. I. Electron microscopic study of the renal lesion in rats.

Authors:  R L VERNIER; B W PAPERMASTER; R A GOOD
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

View more
  11 in total

1.  Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Authors:  Seetharamaiah Chittiprol; Phylip Chen; Danica Petrovic-Djergovic; Tad Eichler; Richard F Ransom
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

2.  CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.

Authors:  D Petrovic-Djergovic; M Popovic; S Chittiprol; H Cortado; R F Ransom; S Partida-Sánchez
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

3.  Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome.

Authors:  W E Smoyer; A Gupta; P Mundel; J D Ballew; M J Welsh
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Lymphocyte blastogenesis in nephrotic syndrome.

Authors:  M A Minchin; K J Turner; G D Bower
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

5.  An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.

Authors:  Y Fujiwara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

6.  Experimental nephrosis: interassociation of proteinuria with impaired lymphocyte blastogenesis.

Authors:  M A Minchin; G D Bower; K J Turner
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

7.  Hypogammaglobulinaemia in nephrotic rats is attributable to hypercatabolism of IgG.

Authors:  M Beaman; S Oldfield; I C MacLennan; J Michael; D Adu
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.

Authors:  E H Garin; T M Barratt
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

9.  Transplantation in infants less than 1 year of age.

Authors:  T E Nevins
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

10.  Impaired primary antibody response in experimental nephrotic syndrome.

Authors:  E H Garin; P J Sausville; G A Richard
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.